More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug use

Journal of Clinical Gastroenterology

Volumn 39, Issue 8, 2005, Pages 722-727

  Yeh, Matthew M ^a,b   Buskell, Zelma J ^c   Seeff, Leonard B ^c,d   Strader, Doris ^c,e   Wright, Elizabeth C ^f   Goodman, Zachary D ^g  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^f NEW ENGLAND RESEARCH INSTITUTES   (United States)

^g ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Hepatitis C; Histologic activity index; Injection drug use; Parenchymal injury

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; COMPARATIVE STUDY; DISEASE COURSE; HEPATITIS C; HISTOLOGIC ACTIVITY INDEX; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFLAMMATION; INJECTION; INJECTION DRUG USE; INJURY SCALE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; BIOPSY; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 23844486583     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000173852.70419.21     Document Type: Article

References (21)

1. Meyer RA, Gordon SC. Epidemiology of hepatitis C virus infection in a suburban Detroit community. Am J Gastroenterol. 1991;86:1224-1226.
2. Gordon SC, Elloway RS, Long JC, et al. The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs intravenous drug use. Hepatology. 1993;18:1338-1343.
3. Jove J, Sanchez-Tapias M, Bruguera M, et al. Posttransfusion vs. sporadic non-A, non-B chronic hepatitis: a clinicopathological and evolutive study. Liver. 1988;8:42-47.
4. Poynard T, Bedossa P, Opolon P. for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups: natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet. 1997;349:825-832.
5. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 1992; 327:1899-1905.
6. Roudot-Thoraval F, Bastie A, Pawlotsky JM, et al. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. Hepatology. 1997;26:485-490.
7. Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology. 1998;28:562-567.
8. Seeff LB, Zimmerman HJ, Wright EC, et al. Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study. Am J Med Sci. 1975;270:41-47.
9. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
10. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000;20:17-35.
11. Rai R, Wilson LE, Astemborski J, et al. Severity and correlates of liver disease in hepatitis C virus-induced injection drug users. Hepatology. 2002;35:1247-1255.
12. Goodman ZD, Ishak KG. Histopathology of hepatitis C infection. Semin Liver Dis. 1995;15:70-81.
13. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000;31:241-246.
14. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol. 2000;32(suppl 1): 39-47.
15. Cerny C, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 1999;30:595-601.
16. Gordon SC. Does the source of infection affect outcome of hepatitis C? Viral Hepatol Rev. 1999;5:205-218.
17. Tong MJ, El-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995;332:1463-1466.
18. Seeff L, Miller R, Rabkin C, et al. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med. 2000;132: 105-111.
19. Crespo J, Lozano JL, de la Cruz F, et al. Prevalence and significance of hepatitis C viremia in chronic active hepatitis. Am J Gastroenterol. 1994; 89:1147-1151.
20. Boyer N, Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol. 2000;32(suppl 1):98-112.
21. Huang EJ, Wright TL, Lake JR, et al. Hepatitis B and C coinfection and persistent hepatitis B infection: clinical outcome and liver pathology after transplantation. Hepatology. 1996;23:396-404.